Article
EMA has published an overview of its key recommendations in 2020 on the authorization and safety monitoring of medicines for human use.
In 2020, EMA recommended 97 medicines for marketing authorization. Of these, 39 had a new active substance which had never been authorized in the European Union before. The Agency recommended one vaccine and one treatment for COVID-19. The infographic includes figures on the authorization of medicines and a selection of new treatments that represent significant progress in their therapeutic areas.
For more information, click here.
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.